0001209191-21-066146.txt : 20211122
0001209191-21-066146.hdr.sgml : 20211122
20211122172630
ACCESSION NUMBER: 0001209191-21-066146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211118
FILED AS OF DATE: 20211122
DATE AS OF CHANGE: 20211122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TANG KEVIN C
CENTRAL INDEX KEY: 0001178579
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 211433729
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TANG CAPITAL PARTNERS LP
CENTRAL INDEX KEY: 0001191935
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 211433726
BUSINESS ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-200-3830
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TANG CAPITAL MANAGEMENT LLC
CENTRAL INDEX KEY: 0001232621
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 211433728
BUSINESS ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-200-3830
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-18
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001178579
TANG KEVIN C
4747 EXECUTIVE DRIVE
SUITE 210
SAN DIEGO
CA
92121
0
0
1
0
0001232621
TANG CAPITAL MANAGEMENT LLC
4747 EXECUTIVE DRIVE
SUITE 210
SAN DIEGO
CA
92121
0
0
1
0
0001191935
TANG CAPITAL PARTNERS LP
4747 EXECUTIVE DRIVE
SUITE 210
SAN DIEGO
CA
92121
0
0
1
0
Common Stock
2021-11-18
4
S
0
43213
9.3845
D
1716787
I
By LP
Common Stock
2021-11-18
4
S
0
152764
8.3234
D
1564023
I
By LP
Common Stock
2021-11-18
4
S
0
4023
8.0015
D
1560000
I
By LP
Common Stock
2021-11-18
4
S
0
169533
8.0947
D
1390467
I
By LP
Common Stock
2021-11-19
4
S
0
30467
8.0123
D
1360000
I
By LP
Common Stock
2021-11-19
4
S
0
183333
7.5205
D
1176667
I
By LP
Common Stock
2021-11-22
4
S
0
16667
7.3589
D
1160000
I
By LP
Common Stock
2021-11-22
4
S
0
196281
7.1081
D
963719
I
By LP
Common Stock
2021-11-22
4
S
0
3719
6.6627
D
960000
I
By LP
Common Stock
2021-11-22
4
S
0
38664
6.5532
D
921336
I
By LP
The prices reported in Column 4 are weighted average prices. These shares were sold in multiple transactions at prices ranging from $9.05 to $10.05. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 1 and 3 through 11 herein.
The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $8.04 to $9.04.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.01.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.34.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $7.78 to $8.15.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $7.20 to $8.09.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $7.20 to $7.54.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $6.69 to $7.69.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $6.66 to $6.68.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $6.50 to $6.71.
/s/ Kevin Tang
2021-11-22
/s/ Kevin Tang, Managing Member
2021-11-22
/s/ Kevin Tang, Managing Member of Tang Capital Management, LLC, General Partner
2021-11-22